Inter- and Intraobserver Variability on Endoscopic Scoring Systems in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis

被引:3
|
作者
Hashash, Jana G. [1 ]
Ng, Faye Yu Ci [2 ]
Farraye, Francis A. [1 ]
Wang, Yeli [2 ]
Colucci, Daniel R. [2 ]
Baxi, Shrujal [2 ]
Muneer, Sadaf [2 ]
Reddan, Mitchell [2 ]
Shingru, Pratik [2 ]
Melmed, Gil Y. [3 ,4 ]
机构
[1] Mayo Clin, Inflammatory Bowel Dis Ctr, Div Gastroenterol & Hepatol, Jacksonville, FL USA
[2] Iterat Hlth Inc, Cambridge, MA USA
[3] Cedars Sinai Med Ctr, Div Gastroenterol & Hepatol, Los Angeles, CA USA
[4] Cedars Sinai, Karsh Div Gastroenterol & Hepatol, 8730 Alden Dr,Thalians Bldg, Los Angeles, CA 90048 USA
关键词
endoscopy; Crohn's disease; ulcerative colitis; endoscopic scoring; interobserver variability; intraobserver variability; RELIABILITY; VALIDATION; AGREEMENT; SEVERITY; SCORES; INDEX;
D O I
10.1093/ibd/izae051
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Endoscopy scoring is a key component in the diagnosis of ulcerative colitis (UC) and Crohn's disease (CD). Variability in endoscopic scoring can impact patient trial eligibility and treatment effect measurement. In this study, we examine inter- and intraobserver variability of inflammatory bowel disease endoscopic scoring systems in a systematic review and meta-analysis.Methods We included observational studies that evaluated the inter- and intraobserver variability using UC (endoscopic Mayo Score [eMS], Ulcerative Colitis Endoscopic Index of Severity [UCEIS]) or CD (Crohn's Disease Endoscopic Index of Severity [CDEIS], Simple Endoscopic Score for Crohn's Disease [SES-CD]) systems among adults (>= 18 years of age) and were published in English. The strength of agreement was categorized as fair, moderate, good, and very good.Results A total of 6003 records were identified. After screening, 13 studies were included in our analysis. The overall interobserver agreement rates were 0.58 for eMS, 0.66 for UCEIS, 0.80 for CDEIS, and 0.78 for SES-CD. The overall heterogeneity (I2) for these systems ranged from 93.2% to 99.2%. A few studies assessed the intraobserver agreement rate. The overall effect sizes were 0.75 for eMS, 0.87 for UCEIS, 0.89 for CDEIS, and 0.91 for SES-CD.Conclusions The interobserver agreement rates for eMS, UCEIS, CDEIS, and SES-CD ranged from moderate to good. The intraobserver agreement rates for eMS, UCEIS, CDEIS, and SES-CD ranged from good to very good. Solutions to improve interobserver agreement could allow for more accurate patient assessment, leading to richer, more accurate clinical management and clinical trial data. This study examined the inter- and intraobserver variability of inflammatory bowel disease endoscopic scoring systems (endoscopic Mayo Score, Ulcerative Colitis Endoscopic Index of Severity, Crohn's Disease Endoscopic Index of Severity, Simple Endoscopic Score for Crohn's Disease) in a systematic review and meta-analysis.
引用
收藏
页码:2217 / 2226
页数:10
相关论文
共 50 条
  • [21] Systematic Review with Meta-analysis: Efficacy and Safety of Upadacitinib in Managing Moderate-to-Severe Crohn's Disease and Ulcerative Colitis
    Niu, Chengu
    Zhang, Jing
    Napel, Mahesh
    Boppana, Leela Krishna Teja
    Anas, Hashem
    Jadhav, Nagesh
    Dunnigan, Karin
    Okolo, Patrick I.
    CLINICAL DRUG INVESTIGATION, 2024, 44 (06) : 371 - 385
  • [22] Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis
    Mao, E. J.
    Hazlewood, G. S.
    Kaplan, G. G.
    Peyrin-Biroulet, L.
    Ananthakrishnan, A. N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (01) : 3 - 13
  • [23] Reply to comment on: "Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease - a systematic review with meta-analysis"
    Attauabi, Mohamed
    Seidelin, Jakob Benedict
    Burisch, Johan
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (02) : 300 - 301
  • [24] Moxibustion for ulcerative colitis: a systematic review and meta-analysis
    Dong-Hyo Lee
    Jong-In Kim
    Myeong Soo Lee
    Tae-Young Choi
    Sun-Mi Choi
    Edzard Ernst
    BMC Gastroenterology, 10
  • [25] Moxibustion for ulcerative colitis: a systematic review and meta-analysis
    Lee, Dong-Hyo
    Kim, Jong-In
    Lee, Myeong Soo
    Choi, Tae-Young
    Choi, Sun-Mi
    Ernst, Edzard
    BMC GASTROENTEROLOGY, 2010, 10
  • [26] Panenteric capsule endoscopy systems in ulcerative colitis: A systematic review and meta-analysis
    Tamilarasan, A. G.
    Tran, Y.
    Paramsothy, S.
    Leong, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 113 - 114
  • [27] Proximal Disease Extension in Limited Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Roda, Giulia
    Narula, Neeraj
    Pinotti, Rachel
    Skamnelo, Alexandros
    Konstantinos, Katsanos H.
    Torres, Joana
    Colombel, Jean-Frederic
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S21 - S21
  • [28] Proximal disease extension in limited ulcerative colitis: a systematic review and meta-analysis
    Roda, G.
    Narula, N.
    Pinotti, R.
    Skamnelos, A.
    Katsanos, K.
    Torres, J.
    Ungaro, R.
    Colombel, J. -F.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S28 - S28
  • [29] PROXIMAL DISEASE EXTENSION IN LIMITED ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Roda, Giulia
    Narula, Neeraj
    Pinotti, Rachel
    Skamnelos, Alexandros
    Katsanos, Konstantinos
    Ungaro, Ryan C.
    Torres, Joana
    Colombel, Jean Frederic
    GASTROENTEROLOGY, 2017, 152 (05) : S976 - S976
  • [30] Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis
    Roda, G.
    Narula, N.
    Pinotti, R.
    Skamnelos, A.
    Katsanos, K. H.
    Ungaro, R.
    Burisch, J.
    Torres, J.
    Colombel, J. -F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (12) : 1481 - 1492